Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-056498
Filing Date
2026-08-13
Accepted
2026-08-13 08:33:06
Documents
84
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-20260630.htm   iXBRL 10-Q 1476498
2 EX-10.1 ovid-consultingagreement.htm EX-10.1 14036
3 EX-31.1 ovidexhibit3112026-q2.htm EX-31.1 10678
4 EX-31.2 ovidexhibit3122026-q2.htm EX-31.2 10635
5 EX-32.1 ovidexhibit3212026-q2.htm EX-32.1 6044
11 ovid-20260630_g1.jpg GRAPHIC 149478
12 ovid-consultingagreement001.jpg GRAPHIC 298926
13 ovid-consultingagreement002.jpg GRAPHIC 311717
14 ovid-consultingagreement003.jpg GRAPHIC 181393
15 ovid-consultingagreement004.jpg GRAPHIC 47154
16 ovid-consultingagreement005.jpg GRAPHIC 168290
  Complete submission text file 0001628280-26-056498.txt   9795357

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovid-20260630.xsd EX-101.SCH 63019
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovid-20260630_cal.xml EX-101.CAL 70926
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovid-20260630_def.xml EX-101.DEF 294608
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovid-20260630_lab.xml EX-101.LAB 716450
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovid-20260630_pre.xml EX-101.PRE 498252
87 EXTRACTED XBRL INSTANCE DOCUMENT ovid-20260630_htm.xml XML 1027388
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 261270210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)